Peer-reviewedCC BYFrontiers in physiology
Ceramidase is involved in metabolic reprogramming of fibroblasts under hypoxia conditions
- 1Laboratory of Applied Physiology and Pharmacology, Department of Pharmacy, DIFARMA, University of Salerno , ,
- 2Biogem Scarl, Istituto di Ricerche Genetiche “Gaetano Salvatore” & CaReBios surl, Ariano Irpino , ,
- 3Complex Operating Unit of Thoracic Surgery, Azienda Ospedaliera di Rilievo Nazionale "San Giuseppe Moscati" (A.O.R.N. Giuseppe Moscati) , ,
Related
- Targeting Metabolic Reprogramming in Cancer: Past, Present, and Future
- HER3 mediates metabolic reprogramming in metastatic colorectal and pancreatic cancer
- Temporal Single-Nucleus Transcriptomics Defines PPARα/CPT1A-Associated Metabolic Reprogramming During Proximal Tubular Injury and Repair
- The Role of Glucose Metabolic Reprogramming in Exercise-Attenuated Osteoporosis: a Narrative Review
- Atrial fibroblast metabolic reprogramming in atrial fibrillation: a candidate mechanism within multicellular atrial cardiomyopathy
BibTeX
@article{terlizzi2026ceramidase,
title = {{Ceramidase is involved in metabolic reprogramming of fibroblasts under hypoxia conditions}},
author = {Michela Terlizzi and Emmanuel D’Andria and Chiara Colarusso and Simone Di Caprio and Anna Falanga and Maria Rosaria Lauro and Rosario Salvi and Rosalinda Sorrentino},
journal = {Frontiers in physiology},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13661358},
note = {CC BY},
}
RIS
TY - JOUR
TI - Ceramidase is involved in metabolic reprogramming of fibroblasts under hypoxia conditions
AU - Michela Terlizzi
AU - Emmanuel D’Andria
AU - Chiara Colarusso
AU - Simone Di Caprio
AU - Anna Falanga
AU - Maria Rosaria Lauro
AU - Rosario Salvi
AU - Rosalinda Sorrentino
PY - 2026
DA - 2026/10/16
JO - Frontiers in physiology
UR - https://europepmc.org/article/PMC/PMC13661358
SN - 1664-042X
ER -